Related Experiment Videos
Adenovirus overrides cellular checkpoints for protein translation
Clodagh C O'Shea1, Serah Choi, Frank McCormick
1UCSF Cancer Center, San Francisco, California 94115, USA. coshea@cc.ucsf.edu
Cell Cycle (Georgetown, Tex.)
|June 23, 2005
Summary
Adenovirus proteins E4-ORF1 and E4-ORF4 activate mTOR signaling, mimicking nutrient and growth factor pathways. This viral mechanism offers insights into cancer cell mTOR dysregulation and DNA replication.
Area of Science:
- Molecular Biology
- Virology
- Cancer Research
Background:
- Mammalian target of rapamycin (mTOR) regulates protein translation and cellular replication.
- Deregulation of mTOR signaling is implicated in human cancers, making it a key therapeutic target.
- The precise mechanisms of mTOR activation, particularly in response to viral infections, remain incompletely understood.
Purpose of the Study:
- To investigate the mechanisms of mTOR activation during adenovirus infection in quiescent cells.
- To identify viral factors responsible for aberrant mTOR activation.
- To explore parallels between viral replication strategies and cancer cell pathways concerning mTOR.
Main Methods:
- Utilized adenovirus as a tool to study mTOR activation in primary quiescent cells.
- Analyzed the roles of viral proteins E4-ORF1 and E4-ORF4 in mTOR pathway modulation.
- Investigated the interaction of viral proteins with host cell signaling pathways like PI3-kinase and PP2A.
Main Results:
- Adenovirus infection activates mTOR independently of nutrient or growth factor signals.
- Viral proteins E4-ORF1 and E4-ORF4 were identified as key activators of mTOR.
- E4-ORF1 activates mTOR by mimicking growth factor signaling via PI3-kinase activation.
- E4-ORF4 activates mTOR by interacting with and relocalizing protein phosphatase 2A (PP2A), substituting for glucose-mediated activation.
Conclusions:
- Adenovirus employs specific viral proteins to inappropriately activate mTOR, facilitating viral replication.
- These viral strategies highlight functional similarities between virus-infected cells and tumor cells regarding mTOR pathway manipulation.
- Understanding these viral mechanisms provides novel insights into targeting mTOR in cancer therapy.